Trial intelligence / Profile preview

Platelet Inhibition and/or Lipid Lowering in Non-ACS Patients with Elevated hs-Troponin

DRKS00017671Phase 3Not yet recruiting

Sponsor
University Heart Center Hamburg
Start
Jan 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of aspirin and atorvastatin in cardiac ischemia (4 arms), sponsored by University Heart Center Hamburg. Planned start Jan 2020; status: not yet recruiting.

02

Drugs

aspirinatorvastatin
03

Conditions

cardiac ischemia

Beyond the preview

Go deeper on DRKS00017671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00017671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call